Specifications
Payment Terms :
T/T
Sideeffects :
Mild swelling, redness, bruising
Biodegradability :
Biodegradable
Supply Ability :
100000
Material :
Poly(D,L-lactic acid)
Onsetofeffect :
Gradual, over weeks
Model Number :
PDLLA03
Particlesize :
Approximately 40 microns
Price :
40USD
Sterility :
Sterile
Injectiondepth :
Deep dermis to subcutaneous layer
Form :
Injectable filler
Packaging Details :
VIALS PACKING
Mechanism :
Stimulates collagen production
MOQ :
1
Delivery Time :
3-5 DAYS
Commontreatmentareas :
Nasolabial folds, cheeks, chin
Longevity :
12 to 24 months
Brand Name :
FITAKH
Indication :
Facial volume restoration and wrinkle correction
Certification :
NMPA ISO13485 GMP
Storageconditions :
Store at 2-25°C, avoid freezing
Place of Origin :
CHINA
Productname :
PDLLA Filler
Description
Amorphous PDLLA Filler with Uniform Degradation and Natural Collagen Regeneration for Anti-Aging
PDLLA Filler Products Description:
  • Technical Principle: Medical-grade PDLLA is an amorphous random copolymer polymerized by DL-lactic acid monomers, featuring a disordered molecular chain structure without regular crystal lattices. Different from crystalline PLLA, its non-crystalline structure delivers softer texture and more uniform tissue compatibility after subcutaneous injection. The core working mechanism relies on mild and steady ester bond hydrolysis in physiological environments. Polymer long chains are gradually decomposed into natural lactic acid, which is further metabolized into carbon dioxide and water with zero toxic residues. During the slow degradation process, PDLLA continuously activates dermal fibroblasts, promotes autologous collagen hyperplasia and regeneration, and realizes the dual effect of physical filling support and biological skin rejuvenation.
  • Production Process: PDLLA adopts strict medical-grade sterile polymerization and deep purification procedures. High-purity DL-lactic acid raw materials are screened and refined to remove impurities, moisture and invalid monomers. Precision ring-opening polymerization is carried out under constant temperature and pressure with controllable catalytic conditions to form uniform high-molecular-weight PDLLA polymers. Multiple devolatilization and ultra-filtration purification processes are applied to thoroughly eliminate residual catalysts and micro-impurities. The whole synthesis, granulation and packaging process is completed in Class 100 dust-free sterile workshops, ensuring ultra-low sensitization, stable molecular weight distribution and consistent batch quality for clinical aesthetic injection.
  • Core Technical Parameters: The core component is medical-grade Poly-DL-Lactic Acid (PDLLA) with ultra-high purity of ≥99.5%. It adopts amorphous random copolymer structure, with customizable molecular weight ranging from 50000 to 100000 Da. The in-vivo degradation cycle is stable at 12 to 18 months. All products comply with ISO 10993 biocompatibility safety standards. The final degradation products are natural lactic acid, carbon dioxide and water, achieving complete metabolism and residue-free safety performance for long-term clinical aesthetic applications.

Amorphous PDLLA Filler Uniform Degradation Injectable Wrinkle Fillers

Amorphous PDLLA Filler Uniform Degradation Injectable Wrinkle Fillers

Send your message to this supplier
Send Now

Amorphous PDLLA Filler Uniform Degradation Injectable Wrinkle Fillers

Ask Latest Price
Payment Terms :
T/T
Sideeffects :
Mild swelling, redness, bruising
Biodegradability :
Biodegradable
Supply Ability :
100000
Material :
Poly(D,L-lactic acid)
Onsetofeffect :
Gradual, over weeks
Contact Supplier
Amorphous PDLLA Filler Uniform Degradation Injectable Wrinkle Fillers
Amorphous PDLLA Filler Uniform Degradation Injectable Wrinkle Fillers

Guangdong Fitakh Pharmaceutical Biotechnology Co., Ltd.

Verified Supplier
1 Years
guangzhou
Since 2020
Business Type :
Manufacturer, Trading Company
Employee Number :
50~100
Certification Level :
Verified Supplier

Find Similar Products By Category:

Contact Supplier
Submit Requirement